Literature DB >> 2342248

C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells.

I Torbohm1, M Schönermark, A M Wingen, B Berger, K Rother, G M Hänsch.   

Abstract

Aside from their lytic function the late complement components C5b-9 stimulate release of prostanoids, interleukin 1 and oxygen radicals from a number of cells. Since C5b-9 has also been connected to the development of sclerosis in animal models of glomerulonephritis, we addressed the question whether C5b-9 would affect the collagen synthesis. We used human glomerular epithelial cells (GEC) obtained as primary outgrowth cultures. The cells were cultivated in the presence of 14C-proline. Collagen synthesis was quantitated by counting the radioactivity associated with collagenase digestible material. Furthermore, collagen was analyzed by SDS-PAGE. GEC in culture produce spontaneously some collagen type IV. Addition of sublytic doses of highly purified C5b-9 increased the collagen synthesis considerably within 12 to 24 hours. In the absence of C9, C5b-8 stimulated collagen synthesis to a similar extent, whereas in the absence of C7 or C8, the collagen synthesis was not enhanced. Furthermore, fluid-phase-formed C5b-9 complexes did not stimulate the collagen synthesis, indicating that assembly of the complex on the target membrane was required. Since C5b-9 deposits are found in sclerotic areas, our data support the hypothesis that C5b-9, by stimulating collagen synthesis as well as release, might contribute to the development of chronic nephritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342248     DOI: 10.1038/ki.1990.91

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Leaked protein and interstitial damage in the kidney: is complement the missing link?

Authors:  N S Sheerin; S H Sacks
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

2.  Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat.

Authors:  L C Paul; J Muralidharan; S A Muzaffar; E H Manting; J F Valentin; E de Heer; M Kashgarian
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation.

Authors:  Takayoshi Miura; Shin Goto; Seitaro Iguchi; Hisaki Shimada; Mitsuhiro Ueno; Shin-ichi Nishi; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2010-11-06       Impact factor: 2.801

4.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

Review 5.  Role of complement and complement regulatory proteins in the complications of diabetes.

Authors:  Pamela Ghosh; Rupam Sahoo; Anand Vaidya; Michael Chorev; Jose A Halperin
Journal:  Endocr Rev       Date:  2015-04-10       Impact factor: 19.871

6.  Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA.

Authors:  B Jahn; J Von Kempis; K L Krämer; S Filsinger; G M Hänsch
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

Review 7.  Immunopathophysiology of trauma-related acute kidney injury.

Authors:  David A C Messerer; Rebecca Halbgebauer; Bo Nilsson; Hermann Pavenstädt; Peter Radermacher; Markus Huber-Lang
Journal:  Nat Rev Nephrol       Date:  2020-09-21       Impact factor: 28.314

8.  Interaction of transforming growth factor beta 1 with human glomerular epithelial cells in culture: opposite effects on synthesis of matrix proteins and on urokinase plasminogen activator.

Authors:  C Wagner; C Viedt; A Bürger; S Filsinger; M Kramer; G M Hänsch
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

Review 9.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

10.  Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain.

Authors:  J Floege; R J Johnson; C E Alpers; S Fatemi-Nainie; C A Richardson; K Gordon; W G Couser
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.